SANTIAGO TOFÉ

Profesor Asociado

University of the Balearic Islands

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Santiago Tofé is an Associate Professor at Universidad de las Islas Baleares, Spain. His research areas include the management of thyroid disorders, diabetes mellitus treatments, and minimally invasive surgical techniques. He has recently published articles focusing on the integration of artificial intelligence in clinical outcomes, cost-effectiveness analyses in thyroid nodule management, and the efficacy of various treatments for type 2 diabetes. Professor Tofé's work contributes significantly to the fields of endocrinology and metabolic syndrome.

Articles (20)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (3)

Simon Heller

Professor of Clinical Diabetes

University of Sheffield

UNITED KINGDOM

View details

Christopher Gilfillan

Adjuct Clinical Professor

MONASH UNIVERSITY

AUSTRALIA

View details

Misericordia Carles-Lavila

Profesora Titular de Universidad

Universitat Rovira i Virgili Departamento de Economía

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

SANTIAGO TOFÉ

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Integrating Artificial Intelligence in Thyroid Nodule Management: Clinical Outcomes and Cost-effectiveness Analysis

Challenges in the diagnosis and follow-up of Cushing’s syndrome: Evaluating LC-MS/MS as a confirmation method for urinary free cortisol analyses

Técnicas mínimamente invasivas para el manejo de los nódulos tiroideos benignos: eficacia e impacto sobre la calidad de vida de la inyección percutánea de etanol. Resultados en una unidad de alta resolución de nódulo tiroideo

Use of Tirzepatide in Adults with Type 2 Diabetes Mellitus: Scientific Evidence and Practical Aspects

Estructura funcional de una unidad de alta resolución de nódulo tiroideo. Impacto económico y resultados de su implantación en un servicio de Endocrinología

Tirzepatide 5, 10 and 15 mg versus injectable semaglutide 0.5 mg for the treatment of type 2 diabetes: An adjusted indirect treatment comparison

Reduction of prevalence of patients meeting the criteria for metabolic syndrome with tirzepatide: a post hoc analysis from the SURPASS Clinical Trial Program.

Minimally invasive offloading osteotomy in the treatment of diabetic foot ulcer: Analysis of 25 patients.

Breaking Barriers With Basal Insulin Biosimilars in Type 2 Diabetes

Effects of weight stigma on BMI and inflammatory markers among people living with obesity

Age-standardized incidence, mortality rate and trend changes of thyroid cancer in the Balearic Islands during the 2000-2020 period: a population-based study.

Age-standardized incidence, mortality rate, and trend changes of thyroid cancer in the Balearic Islands during the 2000–2020 period: a population-based study

Tirzepatide vs Insulin Lispro Added to Basal Insulin in Type 2 Diabetes: The SURPASS-6 Randomized Clinical Trial.

Ultrasound-guided Ethanol Percutaneous Ablation versus Rescue Surgery in Patients with Loco-regional Recurrence of Papillary Thyroid Cancer.

Non-surgical treatment of benign symptomatic thyroid nodules.

Short term effects of semaglutide on emotional eating and other abnormal eating patterns among subjects living with obesity

NON-SURGICAL TREATMENT OF BENIGN SYMPTOMATIC THYROID NODULES,TRATAMIENTO NO QUIRÚRGICO DE LOS NÓDULOS TIROIDEOS BENIGNOS SINTOMÁTICOS

Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial.

Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial

Glucagon-Like Peptide 1 Receptor Agonists in Type 2 Diabetes Mellitus: Data from a Real-World Study in Spain.

Collaborators (3)

Simon Heller

Christopher Gilfillan

Misericordia Carles-Lavila

Make your next move.

SANTIAGO TOFÉ

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Integrating Artificial Intelligence in Thyroid Nodule Management: Clinical Outcomes and Cost-effectiveness Analysis

Challenges in the diagnosis and follow-up of Cushing’s syndrome: Evaluating LC-MS/MS as a confirmation method for urinary free cortisol analyses

Técnicas mínimamente invasivas para el manejo de los nódulos tiroideos benignos: eficacia e impacto sobre la calidad de vida de la inyección percutánea de etanol. Resultados en una unidad de alta resolución de nódulo tiroideo

Use of Tirzepatide in Adults with Type 2 Diabetes Mellitus: Scientific Evidence and Practical Aspects

Estructura funcional de una unidad de alta resolución de nódulo tiroideo. Impacto económico y resultados de su implantación en un servicio de Endocrinología

Tirzepatide 5, 10 and 15 mg versus injectable semaglutide 0.5 mg for the treatment of type 2 diabetes: An adjusted indirect treatment comparison

Reduction of prevalence of patients meeting the criteria for metabolic syndrome with tirzepatide: a post hoc analysis from the SURPASS Clinical Trial Program.

Minimally invasive offloading osteotomy in the treatment of diabetic foot ulcer: Analysis of 25 patients.

Breaking Barriers With Basal Insulin Biosimilars in Type 2 Diabetes

Effects of weight stigma on BMI and inflammatory markers among people living with obesity

Age-standardized incidence, mortality rate and trend changes of thyroid cancer in the Balearic Islands during the 2000-2020 period: a population-based study.

Age-standardized incidence, mortality rate, and trend changes of thyroid cancer in the Balearic Islands during the 2000–2020 period: a population-based study

Tirzepatide vs Insulin Lispro Added to Basal Insulin in Type 2 Diabetes: The SURPASS-6 Randomized Clinical Trial.

Ultrasound-guided Ethanol Percutaneous Ablation versus Rescue Surgery in Patients with Loco-regional Recurrence of Papillary Thyroid Cancer.

Non-surgical treatment of benign symptomatic thyroid nodules.

Short term effects of semaglutide on emotional eating and other abnormal eating patterns among subjects living with obesity

NON-SURGICAL TREATMENT OF BENIGN SYMPTOMATIC THYROID NODULES,TRATAMIENTO NO QUIRÚRGICO DE LOS NÓDULOS TIROIDEOS BENIGNOS SINTOMÁTICOS

Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial.

Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial

Glucagon-Like Peptide 1 Receptor Agonists in Type 2 Diabetes Mellitus: Data from a Real-World Study in Spain.

Collaborators (3)

Simon Heller

Christopher Gilfillan

Misericordia Carles-Lavila

Make your next move.

Tirzepatide 5, 10 and 15 mg versus injectable semaglutide 0.5 mg for the treatment of type 2 diabetes: An adjusted indirect treatment comparison